Pengcheng Xu
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Changes in plasma lipid composition upon glucocorticoid treatment in patients with primary immune thrombocytopenia.
Journal: Clinical and translational medicine
Published: February 18, 2025
YC-4-3, a Novel Glycogen Synthase Kinase 3β Inhibitor, Alleviates the Endoplasmic Reticulum Stress of Macrophages in Primary Immune Thrombocytopenia.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 07, 2024
Genomic characterization of the NAC transcription factors in carnation and function analysis of DcNAC41 involved in thermotolerance.
Journal: Plant physiology and biochemistry : PPB
Published: September 12, 2024
CD163 + M2-like monocytes increase in pregnant women with first-attempted frozen embryo transfer.
Journal: Journal of reproductive immunology
Published: August 28, 2024
Changes in immune subsets during chemotherapy as prognosis biomarkers for multiple myeloma patients by longitudinal monitoring.
Journal: Immunologic research
Published: April 05, 2024
Author Correction: MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages.
Journal: Cellular & molecular immunology
Published: November 01, 2023
Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia.
Journal: Annals of hematology
Published: August 22, 2023
Decreased cyclooxygenase-2 associated with impaired megakaryopoiesis and thrombopoiesis in primary immune thrombocytopenia.
Journal: Journal of translational medicine
Published: May 15, 2023
Lipoprotein lipids and apolipoproteins in primary immune thrombocytopenia: Results from a clinical characteristics and causal relationship verification, potential drug target identification by Mendelian randomization analyses.
Journal: British journal of haematology
Published: April 21, 2023
MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages.
Journal: Cellular & molecular immunology
Published: April 05, 2023
Low-dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter.
Journal: Clinical and translational medicine
Published: March 26, 2023
Last Updated: 09/26/2026